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Abstract
The systemic clinical symptoms of Plasmodium falciparum infection such as fever and chills correspond to the
proinflammatory cytokines produced in response to the parasite components released during the synchronized rupture of
schizonts. We recently demonstrated that, among the schizont-released products, merozoites are the predominant
components that activate dendritic cells (DCs) by TLR9-specific recognition to induce the maturation of cells and to produce
proinflammatory cytokines. We also demonstrated that DNA is the active constituent and that formation of a DNA-protein
complex is essential for the entry of parasite DNA into cells for recognition by TLR9. However, the nature of endogenous
protein-DNA complex in the parasite is not known. In this study, we show that parasite nucleosome constitute the major
protein-DNA complex involved in the activation of DCs by parasite nuclear material. The parasite components were
fractionated into the nuclear and non-nuclear materials. The nuclear material was further fractionated into chromatin and
the proteins loosely bound to chromatin. Polynucleosomes and oligonucleosomes were prepared from the chromatin.
These were tested for their ability to activate DCs obtained by the FLT3 ligand differentiation of bone marrow cells from the
wild type, and TLR2
2/2, TLR9
2/2 and MyD88
2/2 mice. DCs stimulated with the nuclear material and polynucleosomes as
well as mono- and oligonucleosomes efficiently induced the production of proinflammatory cytokines in a TLR9-dependent
manner, demonstrating that nucleosomes (histone-DNA complex) represent the major TLR9-specific DC-immunostimulatory
component of the malaria parasite nuclear material. Thus, our data provide a significant insight into the activation of DCs by
malaria parasites and have important implications for malaria vaccine development.
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Introduction
Malaria is a major infectious disease in many countries of the
tropicalandsubtropicalregionsoftheworld.Nearlyhalfoftheworld
population is at risk of infecting with malaria parasite [1]–[3].
Malaria caused by the parasite, Plasmodium falciparum, alone is
responsible for nearly one million fatalities annually [4]. Efforts to
produce an effective vaccine against malaria have not yet been
successfulduetogapinourknowledgeonthemolecularmechanisms
involved in the development of protective immunity [5], [6].
Innate immunity characterized by the production of proin-
flammatory responses early during the infection plays an
important role in controlling malaria and other pathogenic
infections [6]–[10]. Innate immune responses also play a critical
role in activating the adaptive immune system for the
development of pathogen-specific protective immunity [11],
[12]. Dendritic cells (DCs) are the specialized cells of the innate
immune system that are central to both innate and adaptive arms
of the immune systems [13], [14]. DCs are not only involved in
the early sensing and controlling of invading pathogens by
producing proinflammatory responses and potentiating these
responses by activating NK cells to secrete IFN-c, but also initiate
and shape up cell-mediated and humoral immunity by inducing
Th1/Th2 differentiation of T cells and antibody production by B
cells [15]–[17]. Thus, DCs link the innate immune system to the
adaptive immune system for shaping of an effective protective
immunity against invading pathogens.
Central to the functions of DCs and other antigen presenting cells
suchasmacrophagesoftheinnateimmunesystemistheexpressionof
Toll-likereceptors(TLRs),afamilyofevolutionarilyconserved,signal
transducing transmembrane proteins [18], [19]. TLRs are involved
in the recognition of invading pathogens by interacting with
conserved molecules called pathogen-associated molecular patterns
(PAMPs) [20]–[22]. TLRs are expressed either on cell surfaces or on
the luminal side of endosomal membranes and exhibit discrete
specificity to PAMPs. TLR4 has been shown to recognize bacterial
lipopolysaccharides, TLR9 has been shown to recognize the CpG
ODN-containing motifs of bacterial DNA, and TLR2 recognizes
diverse ligands such as lipoteichoic acid, lipoproteins, and GPIs.
Upon interactions with PAMPs, TLRs transduce signals through
their conserved cytoplasmic segments, activating MAPK and NF-kB
cascades and inducing a wide range of immunological responses,
including the production of cytokines and chemokines and the
upregulation of cell adhesion molecules and costimulatory molecules
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immune system to discriminate various pathogens and initiate
pathogen-specific immune responses [20], [23].
Many of the early clinical manifestations of malaria infection,
including fever and chills, correspond to the secretion of proin-
flammatory mediators by the cells of the innate immune system in
response to parasite components released at high levels by the
synchronous burst of schizont stage parasite-infected erythrocytes
[24], [25]. Recently, we have demonstrated that, among various
components that are released during the P. falciparum schizont burst,
merozoites (MZs) are the major parasite components that trigger
proinflammatory cytokine responses in DCs [26]. Using exogenous
polycationic proteins and by enzymatic degradative studies, we have
demonstrated that parasite DNA is the stimulatory constituent of
MZs that activates cells by TLR9 recognition, and that complex
formation with polycationic proteins is essential for the internalization
of DNA by DCs. However, the nature of endogenous parasite
proteins that complex with DNA, enabling it to enter DCs remains
unknown. In the present study, using DCs obtained by the FLT3
ligand-induced differentiation of mouse bone marrow cells and
mouse spleen DCs, we sought to investigate the nature of protein-
DNA complex in P. falciparum that is responsible for the MZ-induced
activation of DCs. The data show that parasite nucleosome is the
predominantprotein-DNAcomplexthatisresponsiblefortheTLR9-
specific immunostimulatory activity of MZs.
Materials and Methods
Reagents
Cell and parasite culturing reagents, including sodium pyruvate,
non-essential amino acids, 4-aminobenzoic acid, gentamicin and 2-
mercaptoethanol and trypsin, Staphylococcus aureus micrococcal
nuclease, DNase I, calf thymus histones,and PercollHwere purchased
from Sigma-Aldrich (St. Louis, MO). Dulbecco’s modification of
eagle’s medium (DMEM), roswell park memorial institute (RPMI)
1640 medium, and penicillin/streptomycin solution were from
Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS) was from
Atlanta Biologicals (Lawrenceville, GA). Collagenase D was from
Roche Applied Science (Mannheim,Germany),CpG ODN1826 was
from Coley Pharmaceutical (Kanata, ON, Canada). Hoechst 33258
dye from Promega Corp. (Madison, WI). Chicken ovalbumin
323–339
(OVA
323–339) peptide was purchased from Peptides International,
Inc. (Louisville, KY). Dr. Sergei Gregoryev, Department of
Biochemistry and Molecular Biology, Penn State University College
of Medicine, Hershey, Pennsylvania, provided human recombinant
histones, H1, H2A, H2B, H3 and H4.
Human O-positive blood and O-positive plasma were from the
Blood Bank, Hershey Medical Center Hospital, Hershey, PA.
FMS-like tyrosine kinase 3 (FLT3) ligand expressing B16 cell line
was generously provided by Dr. Glenn Dranoff, Harvard
University Medical School [27]. Conditioned medium from
FLT3-expressing B16 cells was prepared as reported previously
[26] and used as a source of FLT3 ligand for the differentiation of
mouse bone marrow cells to DCs (FL-DCs).
Duoset ELISA kits for measuring mouse TNF-a, IL-12p40 and
IFN-c were from R & D Systems (Minneapolis, MN). Anti-mouse
CD11c antibody (clone N418) conjugated microbeads, mouse NK
cell isolation kit, and anti-mouse CD90.2 antibody conjugated
microbeads and magnetic columns for cell separation were from
Miltenyi Biotec Inc. (Auburn, CA). Fluorescein isothiocyante
(FITC)-conjugated antibodies against mouse CD3e (clone 145-
2C11), CD11c (clone N418) and pan NK cells (clone DX5),
phycoerythrin (PE)-conjugated anti-mouse NK1.1 antibody (clone
PK136), PE-Cy5-conjugated antibodies against mouse CD80
(clone 16-10A1), hamster IgG (clone eBio299Arm) isotype control,
CD86 (clone GL1) and rat IgG2ak isotype control, and
allophycocyanin (APC)-conjugated antibodies against mouse
CD40 (clone 1C10) and rat IgG2ak isotype control were from
eBioscience (San Diego, CA). Rabbit anti-human H3 histone
polyclonal antibodies was from Cell Signaling Technology
(Beverly, MA).
Ethics statement
The Institutional Animal Care and Use Committee of the
Pennsylvania State University College of Medicine, Hershey, has
reviewed and approved the protocols (No. 2001-146) for the use of
animals in this study. The Institutional Review Board of the
Pennsylvania State University College of Medicine, Hershey, has
reviewed and approved the protocols (No. HY03-261EP) for the
use of human O-positive blood and O-positive plasma received
from the Blood Bank, Hershey Medical Center Hospital, Hershey,
PA.
Mice
The wild type (WT), OT-II transgenic mice, and TLR2, TLR9
and MyD88 knockout mice (all in C57BL/6J background) were
housed in a pathogen-free environment. The animal care was in
accordance with the institutional guidelines of the Pennsylvania
State University College of Medicine.
P. falciparum parasites culturing
P. falciparum parasites (3D7 strains) were cultured using O-
positive human erythrocytes in RPMI 1640 medium containing
10% human O-positive plasma and 50 mg/ml gentamicin under
90% nitrogen, 5% oxygen and 5% carbon dioxide atmosphere as
described [28]. The cultures were tested for mycoplasma
contamination at 10–15 day intervals using MycoSensor PCR
assay kit from Stratagene (La Jolla, CA).
Fractionation of parasite components and isolation of
polynucleosomes
The parasite nuclear material and polynucleosomes were
prepared as reported previously [29], [30]. The infected red
blood cells (IRBCs) at the late trophozoite and schizont stages were
enriched by centrifugation of the suspensions of RBC and IRBC
mixture from the culture harvests on 60% Percoll cushions at
1500 g for 15 min at 4uC. The enriched IRBC pellet was
suspended in 20 volumes of 0.1% saponin in PBS, pH 7.2,
vortexed, incubated on ice for 10 min, and centrifuged at 2,500 g
at 4uC for 15 min. The pellet was resuspended in the above
solution, vortexed, incubated for 10 min, and centrifuged. The
parasite pellet thus obtained was washed 3 times with cold PBS,
pH 7.2, and suspended in 10 volumes of lysis buffer (20 mM
HEPES, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mM dithiothre-
itol, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1% Triton
X-100) and incubated on ice for 5 min. The suspension was
centrifuged at 5,000 g at 4uC for 10 min, and nuclear material was
washed three times with the lysis buffer to remove membrane
components. Subsequently, to extract loosely bound proteins, the
nuclear material pellet was extracted with 5 volumes of buffer A
(20 mM HEPES, pH 7.5, 0.2 mM EDTA, 0.3 M KCl, 3 mM
MgCl2, 3 mM 2-mercaptoethanol, and 1 mM each of pepstatin,
leupeptin, benzamidine, N-tosyl-L-phenylalanine chloromethyl
ketone, N-ethylmaleimide and 0.4 mM PMSF), centrifuged and
the supernatant containing proteins was collected. To the pellet
(chromatin material) was added drop-wise an equal volume of
buffer A containing 0.6 M KCl and 10% (v/v) glycerol with gentle
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using Dounce homogenizer, and centrifuged. The supernatant
containing the extracted proteins was collected and the chromatin
material was further extracted with 20 volumes of buffer A
containing 0.4 M NaCl and 5% (v/v) glycerol, and centrifuged at
10,000 rpm at 4uC for 10 min. The chromatin pellet was
suspended in 4 volumes of buffer A containing 0.65 M NaCl
and 0.34 M sucrose and sonicated to obtain chromatin material as
a soluble component (polynucleosomes). The process was repeated
two times and the supernatants containing the soluble polynucleo-
somes were pooled. These polynucleosomes preparations con-
tained, in addition to histones, low levels of bound non-histone
proteins and were used in all studies described here.
The various buffer/salt extracts (see above, and also see
Figure 1) were dialyzed for 24 h with two changes of buffer A
containing 0.1 M NaCl and protease inhibitors using 3.5-kDa
molecular size cut off dialysis bags. Finally, the solutions were
dialyzed overnight at 4uC against the same buffer but without
protease inhibitors. The DNA concentration in the polynucleo-
some preparation was estimated by measuring absorption at
260 nm, and by spectrofluorimetry using Hoechst 33258 dye and
measuring emission at 450 nm after excitation at 350 nm in
ISS
TM PC1 Photon Counting Spectrofluorimeter (ISS, Cham-
paign, IL) [32]. The protein content was measured using a micro
BCA protein estimation kit from Pierce (Thermo Scientific,
Rockford, IL) [33]. Aliquots were analyzed by agarose gel
electrophoresis, SDS-PAGE, and Western blotting.
Preparation of parasite histones
To isolate parasite histones [31], the chromatin pellets prepared
as above, were washed three times with 5 volumes of 0.8 M NaCl
in buffer A and then extracted two times, each time, with 10
volumes of 0.25 M HCl, and allowed to stand on ice for 1 h with
occasional mixing. The extracts were centrifuged separately in
Eppendorf tubes at 12, 000 rpm for 5 min to remove insoluble
debris. The 0.8 M NaCl and 0. 25 M HCl extracts (Figure 1) were
dialyzed and DNA contents measured as described above for
various parasite nuclear extracts. Aliquots of parasites extracts
containing histones were analyzed by SDS-PAGE and then were
pooled together for measuring stimulatory activity.
Preparation of mono- and oligonucleosomes
The polynucleosomes (15 mg DNA content) in 200 mlo f2 0m M
HEPES, pH 7.5, containing 0.1 M NaCl, 3 mM CaCl2 and
0.5 mM PMSF was separately treated with different doses of
micrococcal nuclease (0.5 to 50 units/ml) at 37uC for 5 min. The
reaction was stopped by adding 0.1 volume of 0.5 M EDTA and
chilling on ice, and 10 ml aliquots of the enzyme-treated samples
were analyzed by electrophoresis using 2% agarose gel. The
solutions were dialyzed against buffer A containing 0.1 M NaCl
and were used for the stimulation of FL-DCs.
Treatment of polynucleosomes with DNase and trypsin
The polynucleosomes (7.5 mg DNA content) in 100 mlo f2 0m M
HEPES, pH 7.5, containing 0.1 M NaCl and 0.5 mMP M S Fw a s
incubated with 100 mg/ml trypsin at 37uCf o r3 0m i n .T h er e a c t i o n
was stopped by the addition of FBS to a final concentration of 20%.
The non-treated polynucleosome solution incubated at 37uCf o r
30 min was used as a control stimulant. In a separate experiment,
polynucleosome solution (100 ml, 7.5 mg DNA content) was incubat-
ed with DNase I (100 units/ml) at 37uC for 1 h. The enzyme was
inactivated by the addition of 0.5 M EDTA to a final concentration
of 2.5 mM and heating at 65uCf o r1 0m i n .
Isolation of parasite genomic DNA
The IRBCs from parasite cultures harvested at the late
trophozoite stage were lysed with 0.05% of saponin in cold PBS,
pH 7.2. The released parasites were collected by centrifugation at
2,500 g, and washed two times with cold PBS, pH 7.2. Parasites
were lysed with 10 mM Tris-HCl, pH 8.0, containing 20 mM
EDTA, 0.5% SDS, and incubated with 25 mg/ml proteinase K at
56uC overnight. After diluting with an equal volume of water, the
solution was extracted with phenol and chloroform and treated
with RNase. The DNA was precipitated with 10 volumes of
ethanol after the addition of 3 M NaOAc to a final concentration
of 0.3 M. The DNA precipitated was washed with 70% ethanol,
dried and dissolved in water. The DNA concentration was
estimated by measuring the absorption at 260 nm and stored at
220uC until used.
Isolation of mouse spleen cells
Mouse spleens were homogenized and centrifuged at 200 g for
10 min. The pellets were suspended in ammonium chloride
containing RBC lysis solution, diluted with incomplete DMEM,
and passed through 70-mm strainer to obtain a single cell suspension.
NK cells were isolated by magnetic sorting using the mouse NK cell
isolation kit. T cells from the spleens of OT-II mice were isolated
using anti-mouse CD90.2 antibody-conjugated magnetic beads. For
isolation of DCs, homogenized spleens were incubated with
collagenase D (1 mg/ml in incomplete DMEM) at 37uCf o r
30 min, and a single cell suspension prepared as above. DCs were
isolated by magnetic cell sorting using anti-mouse CD11c-conjugated
microbeads; the purity of cells was ,90%.
Preparation of FLT3 ligand-differentiated DCs
Bone marrow cells from WT, TLR2
2/2, TLR9
2/2 and
MyD88
2/2 mice were cultured for 7 or 8 days in complete
DMEM (DMEM containing 10% FBS, 1% penicillin-streptomycin,
1% non-essential amino acids, 1 mM sodium pyruvate, 50 mM2 -
mercaptoethanol) supplemented with 15% of FLT3 ligand
containing conditioned medium obtained by culturing B16 cells
expressing retrovirus-coded FLT3 ligand [26], [34].
Cell stimulation and cytokine analysis
DCs (1610
5/well) were seeded into 96-well flat-bottom plates and
cultured in 200 ml complete medium, and stimulated with MZs,
various parasite components or control ligands Pam3CSK4 (TLR2
ligand, 10 ng/ml), Poly I:C (TLR3 ligand, 2 mg/ml), LPS (TLR4
ligand, 100 ng/ml) or CpG ODN (TLR9 ligand, 2 mg/ml) for 24 h.
Unless otherwise indicated, the MZs and various parasite compo-
nents were used at concentrations corresponding to 2.5 mg/ml DNA
content. In experiments for results shown in Figures 5, 6, 8, 9, S1, S2,
and S4, purified parasite genomic DNA (pDNA) was added at a
concentration of 8 mg/ml. The culture supernatants were collected
and cytokine levels measured by ELISA as reported previously [35].
In co-culturing experiments, DCs (10
5 cells/well) and NK cells
(0.5610
5/well) were cultured in 96-well U-bottom plates and
stimulated with different doses of MZs or polynucleosomes in
200 ml of complete medium. After 36 h, the culture supernatants
were harvested and analyzed for IFN-c by ELISA. FL-DCs (1610
5/
well in 96-well U-bottom plates)were activated with different doses of
polynucleosomes for 6 h and then co-cultured with T cells (0.5610
5/
well) purified from the spleens of OT-II naı ¨ve mice in the presence or
absence of 2 mg/ml OVA
323–339 peptide in 200 mlo fc o m p l e t e
medium. After 72 h, culture supernatants were harvested and
assayed for IFN-c by ELISA. In parallel, DCs, NK cells or T cells
were cultured, stimulated, and culture supernatants used as controls
for ELISA.
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For analysis of costimulatory molecules expression, FL-DCs
(1610
6) were seeded in 24-well plates, cultured in 1 ml of complete
DMEM and stimulated with P. falciparum nuclear material,
polynucleosomes, MZs (each 2.5 mg/ml of DNA content) or CpG
ODN (2 mg/ml). After 24 h, the cells were collected, stained with
FITC-conjugated anti-mouse CD11c antibody, PE-Cy5-conjugated
anti-mouse CD80 antibody and hamster IgG isotype control and
APC conjugated anti-mouse CD40 antibody and rat IgG2ak isotype
control, PE-Cy5-conjugated anti-mouse CD86 antibody and rat
IgG2ak isotype control. After washing, the cells were analyzed by
using Becton-Dickinson FACSCalibur flowcytometer and the results
were analyzed with CellQuest software (BD Biosciences).
Sucrose density gradient centrifugation
MZs (100 ml wet pellet), suspended in 1 ml of PBS, pH 7.2,
were lysed by freezing and thawing, centrifuged and the
supernatant was treated with 80% ammonium sulfate in buffer
A. The precipitated proteins and protein-DNA-complexes were
collected by centrifugation at 10,000 g for 20 min and dissolved in
buffer A (1 ml), and dialyzed against buffer A containing 0.1 M
NaCl and protease inhibitors. The suspension was loaded onto
Figure 1. Fractionation of P. falciparum nuclear material and preparation of polynucleosomes and histones. The parasites released from
the late trophozoite and schizoint stage-infected erythrocytes were lysed in buffer containing 1% Triton X-100. The insoluble nuclear material was
pelleted, extracted with buffer having different salt concentrations to remove proteins loosely bound to the nuclear chromatin material. The
chromatin material was sheared to yield polynucleosomes.
doi:10.1371/journal.pone.0020398.g001
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Beckman Optima LE-80K ultracentrifuge using SW41Ti rotor at
85,000 g for 16 h. 0.5 ml fractions were collected from the top of
the gradient using gradient collector. The fractions were dialyzed
first against buffer A containing 0.1 M NaCl and protease
inhibitors cocktail, and then against the same buffer without
protease inhibitors. Optical density of fractions was measured at
260 nm and 280 nm. The concentrations of DNA and protein
were estimated fluorimetrically using Hoechst 33258 dye [32] and
by the micro BCA method [33], respectively. An aliquot of each
fraction was analyzed by SDS-PAGE and by Western blotting.
The fractions were used for stimulation of DCs.
SDS-PAGE and western blot analysis
SDS-PAGE was performed under reducing conditions using
15% polyacrylamide gels and the gels were stained with
Coomassie Brilliant Blue R250. For Western blot analysis, the
protein bands in the polyacrylamide gels were transferred onto
nitrocellulose membranes. The membranes were blocked with 5%
(w/v) nonfat dry milk in PBS, pH 7.2, containing 0.1% Tween 20,
at room temperature for 1 h, and then incubated with anti-H3
histone antibody in the above buffer containing 2.5% nonfat dry
milk. After washing, the membranes were incubated with
horseradish peroxidase-conjugated anti-rabbit secondary anti-
body, treated with chemiluminescent substrate (SuperSignalH
West Pico Luminol from Thermo Scientific), and exposed to X-
ray films.
Statistical Analysis
The data were plotted as mean values 6 SEM. Statistical
analysis of the data was performed by Student’s t tests and one-
way analysis of variance followed by the Newman-Keuls test.
GraphPad prism software version 3.0 was used for the analysis. P
values,0.05 were considered statistically significant.
Results
The major DC immunostimulatory component of
P. falciparum merozoites resides in the nucleus
Recently, we showed that P. falciparum MZs potently activate DCs
through TLR9 signaling pathway and that DNA is the predominant
immunostimulatory molecule of MZs [26]. Although the MZs
released during the rupture of the schizont stage malaria parasite
infectederythrocytesaremeanttoinvadeerythrocytes,itislikelythat
only a fraction of the released MZs invade erythrocytes and the
reminder is targeted by the innate immune system [36]–[39]. MZs
are short lived and some of them likely undergo lysis in vivo similar to
that has been observed in vitro [40]–[43], presumably releasing their
cellular contents, including DNA. For parasite DNA to enter DCs
and activate TLR9 signaling pathway, it must complex with
polycationic proteins [26]. In the present study, in efforts to
determine the natureof endogenous parasite protein-DNA complex,
we first analyzed stimulatory activity of nuclear components of the
parasite. We have previously showed that cytoplasmic and
membrane components of IRBCs induced little or no inflammatory
cytokine production, although they could activate DCs to upregulate
the cell surface expression of co-stimulatory molecules to certain
extent [26]. Therefore, in this study the IRBC cytoplasmic
components of parasites were not analyzed. The parasites, released
by treating the late trophozoite and schizont stage P. falciparum-
infected erythrocytes with 0.1% saponin, were lysed with buffer
containing 1% Triton X-100 to disrupt parasite vacuolar, plasma
and nuclear membranes to yield nuclear material as a buffer-
insoluble component (Figure 1) [29]. The nuclear material robustly
activated both mouse FL-DCs and spleen DCs in a dose-dependent
manner,inducingtheproductionofTNF-aandIL-12(Figure2).On
DNA equivalent basis,the purified P.falciparumMZsand the parasite
nuclear material exhibited comparable levels of DC-stimulatory
activity (Figure 2). The nuclear material also induced the maturation
of DCs as revealed by the marked increase in the surface expression
of costimulatory molecules, CD40, CD80 and CD86 (Figure 3).
Collectively, these data strongly suggest that the nuclear material
represent the major immunostimulatory component of P. falciparum
MZs that efficiently activates mouse DCs.
P. falciparum polynucleosomes (histone-DNA complex)
efficiently activate DCs to induce proinflammatory
cytokine responses
To characterize the nature of the parasite nuclear immunostimu-
latory component, the nuclear material, obtained as above, was
extracted successively with buffers containing, (i) 0.3 M KCl, (ii)
0.6 M KCl and 10% glycerol, and (iii) 0.4 M NaCl and 5% glycerol,
to remove proteins such as transcription factors that are loosely
associated with chromatin (Figure 1), [30]. SDS-PAGE and agarose
gel electrophoresis, and fluorimetric analysis using Hoechst 33258
dye indicated the presence of proteins but not DNA in the buffer/salt
extracts of the nuclear material (Figures 4A, 4B, and data not shown).
SDS-PAGE and agarose gel electrophoresis revealed that the
chromatin material obtained after depleting most of the loosely
bound proteins contained proteins and DNA (Figures 4A and 4B).
Given that histones are the major proteins that avidly bind to DNA,
we analyzed the chromatin material and the salt extracts by Western
blotting using anti-H3 histone antibodies. The data indicated that the
protein bands having electrophoretic mobility corresponding to the
molecular mass of 10–15 kDa observed in chromatin material were
histones (Figure 4A, lanes 5 and 6, and Figure 4C). Although some
proteins corresponding to the molecular size of histones were
observed in buffer/salt extracts of the nuclear material (Figure 4A),
histones were not detectable in these fractions by Western blotting
(Figure 4C, lanes 1–4). The buffer/salt extracts lacked DNA and
showed no DC stimulatory activity and the activity was fully
associated with the chromatin material (Figure S1). However, upon
addition of parasite genomic DNA, the buffer/salt extracts efficiently
stimulated DCs (Figure S1). Since histones strongly bind DNA, it is
possible that the observed activity of these fractions is due to the
presence of low levels of histones present in these fractions that were
not detectable by Western blotting. Alternatively, the activity was due
to some positively charged non-histone parasite proteins forming
complex with DNA, facilitating its uptake by DCs.
In eukaryotic cells, the chromatin consists of mainly DNA and
highly positively charged histones and is present as a condensed
structure made up of tightly packed nucleosomes, the unit
structures of condensed DNA. The nucleosomes are composed
of 146 bp DNA winding around histone octomers and a ,60-base
pair long linker DNA to which H1 histone binds and helps in
compact packing of nucleosomes [44]. The insoluble parasite
chromatin material, obtained as above, was suspended in buffer
containing 0.65 M NaCl and 0.34 M sucrose and sonicated to
shear DNA. This process solubilized the majority of chromatin
material, yielding soluble polynucleosomes containing high
molecular weight DNA, histones, and appreciable levels of non-
histone proteins (Figures 4A, lanes 5 and 6, and Figure 4B). FL-
DCs were stimulated with polynucleosomes corresponding to
2.5 mg DNA content/ml, which is equivalent to 3610
6 IRBCs/ml
of culture medium. The polynucleosomes robustly activated DCs
in a dose-dependent manner, producing high levels of TNF-a and
IL-12 (see Figure 2). Most of the DC-stimulatory activity of the
parasite nuclear material was present in polynucleosomes and the
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shown); hence, the latter material was not further investigated. At
various concentrations (based on DNA contents) tested, the levels
of TNF-a and IL-12 produced by DCs stimulated with
polynucleosomes were comparable to those of TNF-a and IL-12
secreted by DCs in response to the parasite nuclear material or
whole MZs (see Figure 2). Further, the polynucleosomes efficiently
induced the maturation of DCs as indicated by the marked
upregulation of co-stimulatory molecules, CD40, CD80 and
CD86, on the cell surface (see Figure 3). These results
demonstrated that the parasite nucleosomal component represents
the DC-stimulatory activity of malaria MZs.
TLR9-mediates the activation of DCs by P. falciparum
polynucleosomes and complex formation with histones
is sufficient for the efficient activation of DCs by parasite
DNA
TLR9 has been shown to be the specific receptor for the
recognition of microbial DNA [45], [46]. To determine the
receptor recognition specificity of polynucleosomes, we tested their
stimulatory activity using FL-DCs prepared from the bone
marrows of TLR9
2/2 and MyD88
2/2 mice; DCs from WT
and TLR2
2/2 mice were used as controls. Polynucleosomes
efficiently activated the FL-DCs derived from WT and TLR2
2/2
mice, producing similar levels of TNF-a and IL-12 (Figures 5A
and 5B). In contrast, TLR9
2/2 and MyD88
2/2 DCs showed little
or no activity, indicating that the activity of polynucleosomes is
due to the TLR9-specific recognition of DNA. To further
demonstrate that DNA is the active molecule, polynucleosomes
were treated with DNase. This treatment resulted in the complete
loss of DC-stimulatory activity of polynucleosomes (Figures 5C
and 5D). The addition of the purified parasite genomic DNA to
the DNase-treated polynucleosomes fully restored the activity,
indicating that DNA is the active component. Treatment with
trypsin also abolished almost all of the DC-stimulatory activity of
polynucleosomes (Figures 5C and 5D). The addition of histones to
the trypsin-treated polynucleosomes completely restored the
activity. Further, the activity was also fully restored when
DNase-treated and trypsin-treated polynucleosomes were com-
bined together (Figures 5C and 5D). Studies have shown that DCs
cannot internalize the highly negatively charged DNA molecules
having extended structures [26], [47], [48]. However, complex
formation with highly positively charged polypeptides leads to the
formation of condensed structure, which is internalized by DCs,
thereby presenting DNA to TLR9 in the endosomal compartment
[48]. Consistent with these observations, while parasite genomic
DNA alone was unable to activate DCs, the addition of exogenous
(calf thymus) histones conferred activity to the genomic DNA
(Figure S2). To conclusively demonstrate that histone-DNA
complex is the actual active component, we purified parasite
histones by extracting the nuclear material with 0.8 M NaCl to
remove most of the loosely associated proteins (Figure 6A, lane 2)
followed by 0.25 M HCl extraction. Other parasite proteins were
Figure 2. The nuclear material and polynucleosomes of P. falciparum efficiently activate DCs to produce inflammatory cytokines. FL-
DCs (panels A and B) or spleen DCs (panels C and D) from WT mice were plated in 96-well plates and stimulated with the indicated doses (based
on DNA contents) of nuclear material or polynucleosomes. FL-DCs similarly stimulated with merozoites (MZs, dose indicated by DNA content) or with
a standard CpG ODN were analyzed as controls. The levels of TNF-a and IL-12 in the culture medium were measured by ELISA. Data are
representatives of three independent experiments, each performed in duplicates. Error bar represents mean values 6 SEM.
doi:10.1371/journal.pone.0020398.g002
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preparations (Figure 6A, lanes 3 and 4); the protein band at
,27 kDa has similar molecular weight corresponds to H1 histone,
whereas those below 15 kDa are H3, H2A, H2B and H4,
respectively. The mixture of purified parasite histones (Figure 6A)
and genomic DNA free of parasite proteins efficiently activated
DCs to produce inflammatory cytokines (Figures 6B and 6C).
Thus, collectively, these data demonstrated that parasite histone-
DNA complex is the TLR9-dependent DC-activating constituent
of malaria parasite nuclear material.
Previously, we showed that DCs stimulated with P. falciparum
MZs could activate NK cells to induce the production of IFN-c
[26]. To determine whether this activity of MZs is also
localized to polynucleosomes, we analyzed IFN-c production
by NK cells after stimulation with DCs activated by
polynucleosomes. The NK cells efficiently produced IFN-c
(Figure 7A). On the DNA equivalent basis, the levels of IFN-c
produced by NK cells stimulated with polynucleosome-treated
DCs were comparable with those produced by MZ-treated
coculture of DCs and NK cells. Similarly, the polynucleosome-
stimulated DCs, primed with OVA
323–339 peptide, could
activate OT-II T cells to produce IFN-c (Figure 7B); the
IFN-c levels produced were comparable to those by OT-II T
cells cocultured with MZ-stimulated and OVA
323–339 peptide-
primed DCs. Thus, these results indicate that DC-stimulating
activity of MZs is localized to polynucleosomes.
Mononucleosomes and oligonucleosomes of
P. falciparum efficiently activate DCs
To determine the length of polynucleosomes required for the DC-
stimulatory activity, we prepared mononucleosomes and oligonucleo-
somes ranging in size from 2 to several mononucleosomes by treating
polynucleosomes with various concentrations of micrococcal nucle-
ase. Electrophoretic analysis of the enzyme digestion products
revealed that the enzyme gradually converted polynucleosomes into
oligonucleosomes, as indicated by the decreasein the amounts of high
molecular size polynucleosomes that could barely enter gels,
eventually forming mono and oligonucleosomes having 2–8 mono-
nucleosomes (Figure 8A). Treatment with low concentrations of
micrococcal nuclease (0.5 units/ml) caused a significant increase in
the stimulatory activity of polynucleosomes (Figures 8B and 8C).This
is presumably due to the decreased size of polynucleosomes,
facilitating uptake by DCs and thus resulting in higher level of
polynucleosomes entering and efficiently activating the cells.
Figure 3. P. falciparum nuclear material and polynucleosomes induce the maturation of DCs. FL-DCs prepared from the bone marrow cells
of WT mice were plated in 24-well plates and stimulated with merozoites (MZs), parasite nuclear material or polynucleosomes. DCs stimulated with
MZs or CpG ODN was used as controls. The upregulated surface expression of costimulatory molecules, CD40, CD80 and CD86, were analyzed by flow
cytometry. The percentages of DCs that are positive to each costimulatory molecule are indicated. Data are representatives of two independent
experiments.
doi:10.1371/journal.pone.0020398.g003
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resulted in the formation of mononucleosomes (DNA size ,100 bp,
lane 9 in Figure 8A) and oligonucleosomes (consists of 2–8
mononucleosomes, DNA size 300–1200 bp; lanes 7 and 8 in
Figure 8A). On the basis of DNA content, the activity of
mononucleosomes and oligonucleosomes was ,70% of the stimu-
latory activity of polynucleosomes (Figures 8B and 8C) and the
activity was TLR9 specific (Figures 8D and 8E). The addition of
either histones or purified parasite genomic DNA to untreated
polynucleosomes and micrococcal nuclease-treated polynucleosomes
had no effect on their stimulatory activity (Figures 8B and 8C). These
results suggested that polynucleosome preparations do not contain
significant levels of histone-unbound DNA or free histones. The
moderatelossofactivityuponmicrococcalnucleasetreatmentislikely
due to the cleavage of the exposed linker DNA regions of
polynucleosomes. The results suggested that the nucleotide sequences
of the linker DNA regions of polynucleosomes also contain specific
DNA motifs that are efficiently recognized by TLR9. Alternatively,
the linker DNA regions of chromatin material are more efficiently
recognized by TLR9 because they are not tightly complexed with
histones as in the case of nucleosomes.
Parasite protein-DNA complex represents the major
TLR9-specific activity of P. falciparum merozoite nuclear
material
To further ascertain that the TLR9-specific DC stimulatory
activity of MZs corresponds to the nuclear protein-DNA com-
plex, we lysed MZs by freezing and thawing, and the lysate
was fractionated by sucrose-density gradient centrifugation. Mea-
surement of UV absorption at 260 and 280 nm in various fractions
showed that most of the proteins and DNA are concentrated at the
top one-third portion of the sucrose gradient, while the lower two-
third of the gradient contained low levels of proteins and DNA
(Figure 9A). Agarose gel electrophoresis showed that DNA is present
mainly in fractions 4–10 (Figure S3). SDS-PAGE analysis revealed
that proteins of various sizes are present in all fractions of the sucrose
gradient. Although, proteins having the sizes similar to histones were
observed in all fractions, Western blotting using anti-H3 histone
antibodies indicated the presence of histones only in fractions
corresponding to peak levels of DNA but not in denser fractions
containing low levels of DNA (Figures 9B and 9C). Upon activity
analysis, in additions to fractions (4–10 in Figure 9A) having high
levels of histones and DNA, those fractions (12–20 in Figure 9A) in
which histones are either absent or present at low levels also activated
DCs to produce TNF-aand IL-12 (Figures 9D and 9E). The addition
of parasite genomic DNA, significantly increased the stimulatory
activity of all fractions, producing high levels of TNF-a and IL-12.
The activity of these fractions was TLR9-dependent (Figures 9F and
9G) as DCs deficient in TLR9 unable to produce cytokines. Further,
treatment with DNase abolished .95% of the activity of the fractions
in WT DCs and addition of parasite genomic DNA to the enzyme-
treated fractions restored the TLR9-dependent activity (Figure S4).
Since histones were either absent or present at low levels in fractions
12–20, the observed DC-stimulatory activity of these fractions upon
the addition of genomic DNA could be due to complexing of DNA
with parasite proteins other than histones. However, the possibility of
histones being present at low levels that efficiently complex with
DNA, conferring the activity cannot be ruled out. Nevertheless,
overall, these results agree with the results shown in Figures 2, 6 and
8, confirming that nuclear material containing histone-DNA complex
is the major DC-activating component of P. falciparum MZs.
Discussion
The components of malaria parasite that activate DCs through the
recognition of TLR9 have been controversial [26], [47], [49], [50].
Earlier studies have shown that either hemozoin alone or hemozoin-
Figure 4. The analysis of the parasite nuclear material and extracts of nuclear material. Panel A: The parasite nuclear material,
polynucleosomes and buffer/salt extracts of nuclear material were analyzed for proteins by SDS-PAGE (in each lane 15 mg of protein content/well).
Lane 1, the supernatant of parasite lysate (see Figure 1 for materials in lanes 1–6); lane 2, 0.3 M KCl extract of the nuclear material; lane 3, 0.6 M KCl
extract of the chromatin material; lane 4, 0.4 M NaCl extract of the chromatin material; lane 5, chromatin material after extraction of proteins with
buffer A containing various salts; lane 6, polynucleosomes; lane 7, the mixture of standard recombinant histones, H1, H2A, H2B, H3 and H4. The
mobility of molecular weight marker proteins is indicated to the right. Panel B: The parasite nuclear material and buffer/salt extracts of nuclear
material were electrophoresed on 0.8% agarose gels and the DNA bands were visualized under UV light after ethidium bromide staining. Lane 1,
parasite nuclear material before extraction of proteins that loosely bound to chromatin (see Figure 1 for materials in lanes 1–10); lane 2, chromatin
material pellet after extraction with buffer/0.3 M KCl; lane 3, chromatin material after extraction with buffer/0.6 M KCl; lane 4, chromatin material after
extraction with buffer/0.4 M NaCl; lane 5, soluble polynucleosomes; lane 6, insoluble fibrous material after obtaining polynucleosomes; lane 7,
parasite cytoplasmic material plus membrane fragments; lane 8, 0.3 M KCl extract of nuclear material; lane 9, 0.6 M KCl extract; lane 10, 0.4 M NaCl
extract. Lanes 1–5, materials having 0.5 mg DNA were analyzed. Lane 6, about 60-fold more material as compared to those in lanes 1–5 based on the
total parasite amount used for fractionation. Lanes 7–10, materials equivalent to that in lanes 1–5 based on the total amount of parasite used for
fractionation was loaded. The sizes of standard DNA makers are indicated to the right. Panel C: Western blotting of parasite components as shown in
panel A was done using anti-H3 histone polyclonal antibodies. Lane descriptions are as outlined in panel A.
doi:10.1371/journal.pone.0020398.g004
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However, we recently demonstrated that hemozoin is an inert
material and it neither activates DCs through TLR9-mediated
signaling nor functions as a carrier of DNA into cells [26]. We have
also demonstrated that MZs are the major factor among the
components released during the P. falciparum schizont burst that
activate DCs via TLR9. Furthermore, we have showed that protein-
DNA complex is the major DC-activating constituent of MZs. In the
present study, we obtained multiple evidence that allowed us to
conclude that the histone-DNA complex of the parasite chromatin
material constitutes the TLR9-mediated immunostimulatory activity
of MZs that triggers the activation of DCs leading to the downstream
productionofinflammatory cytokines.Theevidence insupport of our
conclusion includes: (i) Similar to the whole MZs, the parasite nuclear
material or polynucleosomes possess a robust immunostimulatory
activity to stimulate DCs. The ability of the parasite nuclear material
or polynucleosomes to induce the production of proinflammatory
cytokines, TNF-aand IL-12 by DCs,was comparableto that of MZs.
(ii) Like MZs, the nuclear material or polynucleosomes efficiently
upregulated the surface expression of costimulatory molecules such as
CD40, CD80 and CD86 in DCs. (iii) The mononucleosomes and
oligonucleosomes prepared by the digestion of parasite polynucleo-
somes with micrococcal nuclease could efficiently activate DCs to
produce proinflammatory cytokines. (iv) The digestion of polynucleo-
somes with DNase resulted inthe complete loss of stimulatory activity
and the activity was fully restored upon the addition of parasite
genomic DNA to the enzyme-treated samples (see Figure 5). (v) The
treatment of polynucleosomes with trypsin also abolished the
stimulatory activity and the activity was completely regained when
exogenous histones were added to the trypsin-treated samples. (vi)
The mixture of the DNase-digested polynucleosomes and the trypsin-
treated polynucleosomes could efficiently activate DCs; on the basis
of DNA content, the stimulatory activity of the mixture was
comparable to that of untreated polynucleosomes (see Figure 5).
(vii) Finally, the purified parasite genomic DNA, which cannot by
itself enter and activate DCs [26], showed efficient stimulatory
Figure 5. Analysis of the immunostimulatory activity and TLR specificity of P. falciparum polynucleosomes. Panels A and B: FL-DCs
prepared from the bone marrow of WT, TLR2
2/2, TLR9
2/2 and MyD88
2/2 mice were stimulated with the parasite nuclear material or with the
indicated doses (based on DNA content) of polynucleosomes. FL-DCs stimulated with Pam3CSK4, Poly I:C, LPS or CpG ODN were used as controls. The
levels of TNF-a and IL-12 in the culture supernatants were measured by ELISA. Panels C and D: TNF-a and IL-12 produced by FL-DCs from WT mice
stimulated with polynucleosomes, DNase-treated polynucleosomes, DNase-treated polynucleosomes to which parasite genomic DNA (pDNA) was
added, trypsin-treated polynucleosomes, trypsin-treated polynucleosomes to which histones (1 mg/ml) were added or mixture of DNase- and trypsin-
treated polynucleosomes. The culture supernatants of DCs stimulated with 8 mg/ml parasite genomic DNA (pDNA) and CpG ODN were analyzed as
controls. Experiments were repeated three times and each time performed in duplicates. Error bars represent mean values 6 SEM.
doi:10.1371/journal.pone.0020398.g005
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demonstrate that histone-DNA complex of parasite nucleosomes is
the TLR9-specific, DC-activating factor of malaria parasites.
Previously, other protozoan parasites such as Toxoplasma gondii,
Trypanosoma cruzii and Leishmania major have been shown to activate
DCs through the DNA-mediated recognition of TLR9 [51]–[56].
However, how the negatively charged DNA with a highly
extended structure gain entry into cells has not been reported.
The results of this study clearly show that complexing of DNA
with proteins, presumably to form condensed DNA structures, is
essential for the facile entry of DNA to the endosomal
compartments. Our findings agree with the results of a previous
study that, in bacteria-induced skin psoriasis, DNA complexes with
Figure 6. P. falciparum histone-DNA complex efficiently activate
DCs. Panels A: The parasite chromatin material, 0.8 M NaCl extract of
chromatin material, and 0.25 M HCl extracts of chromatin material
(Figure 1) were analyzed by SDS-PAGE using 15% gels. Each lane was
loaded with 10 mg of protein. Lane 1, polynucleosomes; lane 2, 0.8 M
NaCl extract of the chromatin material; lane 3 and 4, 0.25 M HCl extracts
(histones). The mobility of molecular weights of marker proteins is
indicated to the right. Panels B and C: TNF-a and IL-12 produced by
FL-DCs obtained from WT mice stimulated with different doses of
isolated parasite histones with or without parasite genomic DNA
(pDNA, 8 mg/ml). DCs stimulated with parasite genomic DNA (pDNA,
8 mg/ml), CpG (2 mg/ml) and polynucleosomes (2.5 mg DNA content/ml)
were analyzed as controls. Error bars represents mean values 6 SEM.
doi:10.1371/journal.pone.0020398.g006
Figure 7. P. falciparum polynucleosomes-activated DCs stimu-
late NK cells and OT-II T cells to produce IFN-c. Panel A: WT FL-
DCs were cocultured with NK cells and stimulated with the indicated
doses of polynucleosomes (based on DNA content). After 36 h, the IFN-
c produced by NK cells was measured by ELISA. Merozoites (MZs)
having the indicated DNA contents and CpG ODN were used as
controls. Panel B: WT FL-DCs were stimulated with the indicated doses
of polynucleosomes for 6 h and then cocultured with OT-II T cells in the
presence of OVA
323–339 peptide. After 72 h, the IFN-c produced by T
cells was measured by ELISA. In parallel NK cells, DCs or T cells were
cultured individually or cocultures of DCs and T cells in presence or
absence of OVA
323–339 peptide, but not stimulated with polynucleo-
somes, were used as controls. Data are representative of two
independent experiments, each performed in duplicates. Error bars
represents mean values 6 SEM.
doi:10.1371/journal.pone.0020398.g007
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condensed DNA structure, thereby efficiently entering into DCs
and activating cells through TLR9-mediated signaling and
producing inflammatory cytokines [48]. In fact, the property of
LL37 and other a-helical cationic peptide to form a tight complex
with DNA has been exploited for the transfection of DNA to cells
[57]–[60].
In addition to the histone-DNA complex, nonhistone proteins of P.
falciparum appear to complex with DNA, thereby activating DCs in a
TLR9-dependent manner to induce the production of proinflamma-
tory cytokine responses. This is obvious by our observations that
buffer/salt extracts of parasite nuclear material that contain little or no
histone exhibit activity when supplemented with the purified parasite
genomic DNA (see Figure S1). In addition, the fractions from the
sucrose density gradient centrifugation of parasite lysates that contain
DNA but either lack or have very low levels of histones could stimulate
D C st op r o d u c ei n f l a m m a t o r yc y t o k i n e s( s e eF i g u r e9 ) .M Z sr e l e a s e d
by the burst of schizont stage malaria parasites are labile. Unless they
quickly invade erythrocytes or immediately taken up by phagocytosis,
MZs probably undergo lysis in vivo [36]–[43]. Since malaria parasites
are transcriptionally active throughout their blood stage development,
it is likely that, upon parasite lysis, euchromatin region containing
DNA as an extended structure not complexed with histones is released
by shearing. The positively charged nonhistone parasite proteins can
complex with these free DNA segments, forming protein-DNA
complex, which activates DCs in a manner similar to histone-DNA
complex of nucleosomes. Although our results point out that parasite
proteins other than histones can also confer activity to DNA, their
contributions as compared to histones may be minor.
In conclusion, the results of the present study demonstrate that
histone-DNA complex of the nucleosome is the major TLR9-
dependent immunostimulatory, DC-activating component of P.
falciparum. The polynucleosomes as well as mono- and low molecular
weight oligonucleosomes can efficiently activate DCs in a TLR9-
specific manner to induce the production of proinflammatory
cytokines. Our results also suggest that, to certain extent, parasite
proteins other than histones, those presumably having net positive
charges, may form complex with parasite DNA, activating DCs to
Figure 8. The P. falciparum mononucleosomes and oligonucleosomes efficiently activate DCs to induce the production of
proinflammatory cytokines. Panel A: The parasite polynucleosomes (15 mg DNA content in 200 ml buffer) were treated with the indicated
concentrations of micrococcal nuclease and 10 ml aliquots of the enzyme-digestion products (0.75 mg DNA content) were analyzed by electrophoresis
using 2% agarose gels. Lane 1, untreated polynucleosomes; lane 2, polynucleosomes incubated with buffer only; lanes 3 to 9, respectively were
polynucleosomes treated with 0.5, 1.0, 2.0, 5.0, 10, 20 and 50 units/ml of micrococcal nuclease. The sizes of DNA standards are indicated to the right.
Panels B to E: TNF-a and IL-12 produced by WT FL-DCs stimulated with mono- or oligonucleosomes obtained by different doses of micrococcal
nuclease treatment of polynucleosomes (panels B and C) or FL-DCs from WT, TLR2
2/2, TLR9
2/2 and MyD88
2/2 stimulated with parasite
oligonucleosomes (panels D and E). FL-DCs stimulated with Pam3CSK4, Poly I:C, LPS or CpG ODN were analyzed as controls. The analysis was
performed three times each time in duplicates, and results of a representative experiment are shown. Error bars represent mean values 6 SEM.
* p,0.05, comparison between 0.5 units/ml of micrococcal nuclease digested and undigested polynucleosomes.
doi:10.1371/journal.pone.0020398.g008
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lysate by sucrose-density gradient centrifugation. The values of absorption at 260 nm (,) and 280 nm ( ), and DNA contents (O) of the fractions
were measured as described in ‘‘Materials and Methods’’, and plotted. Panel B: SDS-PAGE analysis. The sucrose gradient fractions were dialyzed;
aliquots corresponding to 20 mg of proteins were analyzed by SDS-PAGE using 15% gels. Sucrose gradient fraction numbers are indicated at the
top. The mobility of molecular weight marker proteins is indicated to the left. Lane S, a mixture of standard H1, H2A, H2B, H3 and H4 histones.
Panel C: Western blotting of sucrose gradient fractions using anti-H3 histone polyclonal antibodies. Lane descriptions are same as that in panel
B. Panels D and E: TNF-a and IL-12 produced by WT FL-DCs stimulated with the indicated sucrose gradient fractions having 2.5 mg/ml of DNA
content or with fractions having 2.5 mg/ml of DNA content to which the purified parasite genomic DNA (pDNA, 8 mg/ml) was added. Cells
stimulated with parasite genomic DNA were used as controls. Panels F and G: TNF-a and IL-12 produced by FL-DCs from WT, TLR2
2/2,
TLR9
2/2 and MyD88
2/2 stimulated with sucrose gradient fractions. DCs stimulated with Pam3CSK4, Poly I:C, LPS, CpG ODN or parasite genomic
DNA were used as a control. The analysis was repeated three times each time performed in duplicates, and results of a representative are
shown. Error bars represent mean values 6 SEM. * p,0.05; ** p,0.01 comparison between sucrose gradient fractions with and without added
parasite DNA.
doi:10.1371/journal.pone.0020398.g009
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the development of immunotherapeutics and/or an effective vaccine
for malaria.
Supporting Information
Figure S1 Non-histone proteins of P. falciparum confer
low level of stimulatory activity to parasite genomic
DNA. Panels A to D: TNF-a and IL-12 produced by WT FL-
DCs stimulated with the parasite cytoplasmic material plus
membrane fragments or buffer/salt extracts (see Figure 1) with
or without added parasite genomic DNA (pDNA). DCs stimulated
with MZs lysate nuclear material (see Figure 1, 2.5 mg/ml DNA
content) or CpG ODN (2 mg/ml) was used as controls. Data are
representative of two independent experiments, each performed in
duplicates. Error bars represent mean values 6 SEM.
(TIF)
Figure S2 Histones are the major carriers of P.
falciparum DNA entry into DCs to induce cytokine
responses. Panels A and B: TNF-a and IL-12 produced by
WT FL-DCs stimulated with parasite genomic DNA (pDNA) plus
the indicated doses of histones were measured using ELISA. Cells
similarly stimulated with CpG ODN were used as a control. Data
are representative of two independent experiments and each time
done in duplicates.
(TIF)
Figure S3 Agarose gel electrophoresis of sucrose gradi-
ent fractions. The sucrose gradient fractions (see Figure 9) were
analyzed for DNA by 1% agarose gel electrophoresis. The fraction
numbers are indicated at the top of the panel. The mobility of
DNA molecular marker standards is indicated to the right.
(TIF)
Figure S4 The stimulatory activity in the sucrose
gradient fractions is due to DNA. Panels A and B: TNF-
a and IL-12 produced by WT FL-DCs stimulated with sucrose
density gradient fractions (see Figure 9; 2.5 mg/ml DNA content).
The sucrose gradient fractions were also analyzed after treatment
with DNase with or without the addition of purified genomic DNA
(pDNA, 8.0 mg/ml). The culture supernatants of DCs stimulated
with 8.0 mg/ml of genomic DNA (pDNA) alone or CpG ODN
(2 mg/ml) were used as controls. Data are representative of two
independent experiments, each performed in duplicates. Error
bars represent mean values 6 SEM.
(TIF)
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